Csenge Advisory Group Kala Pharmaceuticals, Inc. Transaction History

Csenge Advisory Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$0.3 - $1.31 $300 - $1,310	-1,000 Reduced 4.78%	19,924 $6,000
Q1 2022 May 09, 2022	BUY	$0.61 - $1.84 $12,763 - $38,500	20,924 New	20,924 $29,000
Q4 2021 Feb 10, 2022	SELL	$1.16 - $2.74 $22,330 - $52,745	-19,250 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$2.62 - $5.43 $50,435 - $104,527	19,250 New	19,250 $53,000
Q2 2021 Jul 21, 2021	SELL	$5.06 - $8.15 $50,599 - $81,500	-10,000 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$6.24 - $9.58 $28,080 - $43,110	-4,500 Reduced 31.03%	10,000 $76,000
Q4 2020 Jan 26, 2021	BUY	$6.28 - $8.79 $91,060 - $127,454	14,500 New	14,500 $98,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.